Zhang Lei, Evans Anna, von Ruhland Chris, Draman Mohd Shazli, Edkins Sarah, Vincent Amy E, Berlinguer-Palmini Rolando, Rees D Aled, Haridas Anjana S, Morris Dan, Tee Andrew R, Ludgate Marian, Turnbull Doug M, Karpe Fredrik, Dayan Colin M
School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle NE2 4HH, UK.
Int J Mol Sci. 2020 Nov 30;21(23):9145. doi: 10.3390/ijms21239145.
Depot specific expansion of orbital-adipose-tissue (OAT) in Graves' Orbitopathy (GO) is associated with lipid metabolism signaling defects. We hypothesize that the unique adipocyte biology of OAT facilitates its expansion in GO. A comprehensive comparison of OAT and white-adipose-tissue (WAT) was performed by light/electron-microscopy, lipidomic and transcriptional analysis using ex vivo WAT, healthy OAT (OAT-H) and OAT from GO (OAT-GO). OAT-H/OAT-GO have a single lipid-vacuole and low mitochondrial number. Lower lipolytic activity and smaller adipocytes of OAT-H/OAT-GO, accompanied by similar essential linoleic fatty acid (FA) and (low) FA synthesis to WAT, revealed a hyperplastic OAT expansion through external FA-uptake via abundant (FA-transporter) expression. Mitochondrial dysfunction of OAT in GO was apparent, as evidenced by the increased mRNA expression of uncoupling protein 1 () and mitofusin-2 () in OAT-GO compared to OAT-H. Transcriptional profiles of OAT-H revealed high expression of Iroquois homeobox-family (), and low expression in -family/ (essential for WAT/BAT (brown-adipose-tissue)/BRITE (BRown-in-whITE) development). We demonstrated unique features of OAT not presented in either WAT or BAT/BRITE. This study reveals that the pathologically enhanced FA-uptake driven hyperplastic expansion of OAT in GO is associated with a depot specific mechanism (the FA-transporter) and mitochondrial dysfunction. We uncovered that OAT functions as a distinctive fat depot, providing novel insights into adipocyte biology and the pathological development of OAT expansion in GO.
格雷夫斯眼眶病(GO)中眼眶脂肪组织(OAT)的特定部位扩张与脂质代谢信号缺陷有关。我们推测,OAT独特的脂肪细胞生物学特性促进了其在GO中的扩张。通过光学/电子显微镜、脂质组学以及使用离体白色脂肪组织(WAT)、健康OAT(OAT-H)和GO患者的OAT(OAT-GO)进行转录分析,对OAT和WAT进行了全面比较。OAT-H/OAT-GO有单个脂质空泡且线粒体数量较少。OAT-H/OAT-GO的脂肪分解活性较低且脂肪细胞较小,同时其必需亚油酸(FA)和(低水平的)FA合成与WAT相似,这表明通过大量(FA转运蛋白)表达从外部摄取FA,OAT发生了增生性扩张。与OAT-H相比,OAT-GO中解偶联蛋白1()和线粒体融合蛋白2()的mRNA表达增加,这证明了GO中OAT的线粒体功能障碍。OAT-H的转录谱显示,Iroquois同源盒家族()高表达,而在家族/(对WAT/棕色脂肪组织(BAT)/白色棕色脂肪(BRITE)发育至关重要)中低表达。我们证明了OAT具有WAT或BAT/BRITE中均未出现的独特特征。这项研究表明,GO中OAT的病理性增强的FA摄取驱动的增生性扩张与特定部位机制(FA转运蛋白)和线粒体功能障碍有关。我们发现OAT作为一个独特的脂肪库发挥作用,为脂肪细胞生物学以及GO中OAT扩张的病理发展提供了新的见解。